Market Cap 583.42M
Revenue (ttm) 40,000.00
Net Income (ttm) -88.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -220,225.00%
Debt to Equity Ratio 0.15
Volume 3,162,900
Avg Vol 4,238,504
Day's Range N/A - N/A
Shares Out 194.47M
Stochastic %K 57%
Beta 0.27
Analysts Strong Sell
Price Target $14.32

Company Profile

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Industry: Biotechnology
Sector: Healthcare
Phone: 240 654 1450
Address:
910 Clopper Road, Suite 201S, Gaithersburg, United States
jayessbee
jayessbee Aug. 5 at 11:20 PM
$ALT Just got this. The trial is CRAVE. See my comment below.
2 · Reply
Blackfin23
Blackfin23 Aug. 5 at 11:15 PM
0 · Reply
CrappieDude
CrappieDude Aug. 5 at 10:48 PM
$ALT Many times this past year I’ve felt like a dumba$$ bag holder with my $8+ avg. It occurred to me today that Blackrock & Vanguard are still holding ‘lots’ purchased near or even above my average. These firms have some pretty smart mfers, therefore by holding I am a pretty smart mfer too! Tell me why a bidding war that makes Metsera look like chump change isn’t in our NEAR future?
1 · Reply
BioRich
BioRich Aug. 5 at 10:23 PM
$ALT it was inevitable. VA (Veteran Affairs) starting a trial using Semaglutide to test AUD. Seems like typical $ALT of always showing up too late. 3 of the most attractive sectors are their core and they just seem to be a has been at this point. Maybe Durso can get a $2.1B deal to get thisnout of their hands and into BPs hands to promote Pemvi as a Swiss Army option. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. Let's make some (more) money. Cheers! $NVO $VKTX $LLY $XBI
4 · Reply
Duediligence20
Duediligence20 Aug. 5 at 9:55 PM
$NLST $ALT $TNXP Hope you guys caught the Netlist Train Today. Long Runway to go with 33M shares short or 11% of its outstanding float. Large% of The Short Interest is now OOTM so tomorrow could be a bigger Day as they get margin calls and continue to pay 10+% borrowing fees. Netlist is a company with over 200 patents and 120 or so active ones. Samsung agreed to a settlement and licensing fees for Netlist IP which they were co-defendant’s in litigation along with Google, Micron Tech. SK Hynik is in the process of announcing another licensing agreement, so that coupled with deals expected from Google and Micron to follow suit will likely create a huge updraft. We shall celebrate with $ALT and $TNXP soon, but don’t miss this opportunity.
1 · Reply
jangiscon
jangiscon Aug. 5 at 9:12 PM
$ALT their pivot to bamboo panty liners could save them!
0 · Reply
MySfinktrReeks
MySfinktrReeks Aug. 5 at 9:10 PM
$ALT LOL everyone. We're pinned. Market manipulation. Shorts are scared. We are just plain
0 · Reply
Turribull
Turribull Aug. 5 at 9:06 PM
$ALT Commandments this week: Monday: Thou shalt not breach 3. Tuesday: Thou shalt not fall below 3. Wednesday: Thou shalt be 3. Thursday-Friday rinse and repeat?
4 · Reply
GreenEnergy7B
GreenEnergy7B Aug. 5 at 9:00 PM
0 · Reply
Beebop425
Beebop425 Aug. 5 at 8:52 PM
$ALT https://x.com/KatrinaHelle/status/2085106045614014472?s=20
1 · Reply
Latest News on ALT
Altimmune initiates PERFORMA trial

2026-08-03T12:16:41.000Z - 2 days ago

Altimmune initiates PERFORMA trial


H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune

2026-07-28T15:20:26.000Z - 8 days ago

H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune


Altimmune Transcript: Study result

Jul 28, 2026, 8:00 AM EDT - 8 days ago

Altimmune Transcript: Study result


Altimmune Press release: Study result

Jul 28, 2026, 8:00 AM EDT - 8 days ago

Altimmune Press release: Study result


Altimmune Slides: Study result

Jul 28, 2026, 8:00 AM EDT - 8 days ago

Altimmune Slides: Study result


Altimmune announces RECLAIM trial met primary endpoint

2026-07-28T11:26:01.000Z - 8 days ago

Altimmune announces RECLAIM trial met primary endpoint


Altimmune initiated with an Outperform at Leerink

2026-06-22T10:46:24.000Z - 6 weeks ago

Altimmune initiated with an Outperform at Leerink


Altimmune initiated with an Outperform at Leerink

2026-06-22T10:31:03.000Z - 6 weeks ago

Altimmune initiated with an Outperform at Leerink


Altimmune to Participate in Upcoming Investor Conferences

May 27, 2026, 8:30 AM EDT - 2 months ago

Altimmune to Participate in Upcoming Investor Conferences


Altimmune Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 2 months ago

Altimmune Slides: Corporate presentation


Altimmune price target lowered to $11 from $14 at Citizens

2026-05-14T09:47:49.000Z - 2 months ago

Altimmune price target lowered to $11 from $14 at Citizens


Altimmune Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

Altimmune Earnings Call Transcript: Q1 2026


Altimmune Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

Altimmune Earnings release: Q1 2026


Altimmune Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

Altimmune Quarterly report: Q1 2026


Altimmune reports Q1 EPS (18c), consensus (25c)

2026-05-13T11:59:47.000Z - 3 months ago

Altimmune reports Q1 EPS (18c), consensus (25c)


Altimmune management to meet with Piper Sandler

2026-04-27T19:56:05.000Z - 3 months ago

Altimmune management to meet with Piper Sandler


Altimmune upgraded to Neutral from Sell at Goldman Sachs

2026-04-24T09:16:13.000Z - 3 months ago

Altimmune upgraded to Neutral from Sell at Goldman Sachs


Altimmune 64.25M share Spot Secondary priced at $3.00

2026-04-23T11:06:36.000Z - 3 months ago

Altimmune 64.25M share Spot Secondary priced at $3.00


Altimmune announces common stock offering, no amount given

2026-04-22T20:28:30.000Z - 3 months ago

Altimmune announces common stock offering, no amount given


Altimmune Transcript: AGM 2026

Apr 16, 2026, 8:30 AM EDT - 3 months ago

Altimmune Transcript: AGM 2026


Altimmune initiated with a Buy at Truist

2026-03-18T20:00:19.000Z - 5 months ago

Altimmune initiated with a Buy at Truist


Altimmune Proxy statement: Proxy Filing

Mar 17, 2026, 8:00 AM EDT - 5 months ago

Altimmune Proxy statement: Proxy Filing


Altimmune Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 9:20 AM EDT - 5 months ago

Altimmune Transcript: Leerink Global Healthcare Conference 2026


Altimmune Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 2:15 PM EDT - 5 months ago

Altimmune Transcript: The Citizens Life Sciences Conference 2026


Altimmune Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 5 months ago

Altimmune Slides: Corporate presentation


Altimmune Proxy statement: Proxy Filing

Mar 6, 2026, 7:00 AM EST - 5 months ago

Altimmune Proxy statement: Proxy Filing


Altimmune Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Altimmune Earnings Call Transcript: Q4 2025


Altimmune Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Altimmune Annual report: Q4 2025


Altimmune Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Altimmune Earnings release: Q4 2025


Altimmune Transcript: Study Result

Dec 19, 2025, 8:00 AM EST - 8 months ago

Altimmune Transcript: Study Result


Altimmune Press release: Study Result

Dec 19, 2025, 8:00 AM EST - 8 months ago

Altimmune Press release: Study Result


Altimmune Slides: Study Result

Dec 19, 2025, 8:00 AM EST - 8 months ago

Altimmune Slides: Study Result


Altimmune Announces CEO Transition and Succession Plan

Dec 1, 2025, 7:30 AM EST - 8 months ago

Altimmune Announces CEO Transition and Succession Plan


Altimmune Registration statement: Registration Filing

Nov 13, 2025, 7:00 AM EST - 9 months ago

Altimmune Registration statement: Registration Filing


Altimmune Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 10:00 AM EST - 9 months ago

Altimmune Transcript: Stifel 2025 Healthcare Conference


Altimmune Slides: Corporate Presentation

Nov 6, 2025, 4:00 PM EST - 9 months ago

Altimmune Slides: Corporate Presentation


Altimmune Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 9 months ago

Altimmune Earnings Call Transcript: Q3 2025


Altimmune Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 9 months ago

Altimmune Quarterly report: Q3 2025


Altimmune Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 9 months ago

Altimmune Earnings release: Q3 2025


Altimmune Registration statement: Registration Filing

Nov 6, 2025, 7:00 AM EST - 9 months ago

Altimmune Registration statement: Registration Filing


Altimmune to Participate in Two Upcoming Investor Conferences

Nov 5, 2025, 7:30 AM EST - 9 months ago

Altimmune to Participate in Two Upcoming Investor Conferences


Altimmune Transcript: Stifel Virtual Cardiometabolic Forum

Sep 30, 2025, 10:30 AM EDT - 11 months ago

Altimmune Transcript: Stifel Virtual Cardiometabolic Forum


Altimmune Transcript: AGM 2025

Sep 25, 2025, 8:30 AM EDT - 11 months ago

Altimmune Transcript: AGM 2025


jayessbee
jayessbee Aug. 5 at 11:20 PM
$ALT Just got this. The trial is CRAVE. See my comment below.
2 · Reply
Blackfin23
Blackfin23 Aug. 5 at 11:15 PM
0 · Reply
CrappieDude
CrappieDude Aug. 5 at 10:48 PM
$ALT Many times this past year I’ve felt like a dumba$$ bag holder with my $8+ avg. It occurred to me today that Blackrock & Vanguard are still holding ‘lots’ purchased near or even above my average. These firms have some pretty smart mfers, therefore by holding I am a pretty smart mfer too! Tell me why a bidding war that makes Metsera look like chump change isn’t in our NEAR future?
1 · Reply
BioRich
BioRich Aug. 5 at 10:23 PM
$ALT it was inevitable. VA (Veteran Affairs) starting a trial using Semaglutide to test AUD. Seems like typical $ALT of always showing up too late. 3 of the most attractive sectors are their core and they just seem to be a has been at this point. Maybe Durso can get a $2.1B deal to get thisnout of their hands and into BPs hands to promote Pemvi as a Swiss Army option. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. Let's make some (more) money. Cheers! $NVO $VKTX $LLY $XBI
4 · Reply
Duediligence20
Duediligence20 Aug. 5 at 9:55 PM
$NLST $ALT $TNXP Hope you guys caught the Netlist Train Today. Long Runway to go with 33M shares short or 11% of its outstanding float. Large% of The Short Interest is now OOTM so tomorrow could be a bigger Day as they get margin calls and continue to pay 10+% borrowing fees. Netlist is a company with over 200 patents and 120 or so active ones. Samsung agreed to a settlement and licensing fees for Netlist IP which they were co-defendant’s in litigation along with Google, Micron Tech. SK Hynik is in the process of announcing another licensing agreement, so that coupled with deals expected from Google and Micron to follow suit will likely create a huge updraft. We shall celebrate with $ALT and $TNXP soon, but don’t miss this opportunity.
1 · Reply
jangiscon
jangiscon Aug. 5 at 9:12 PM
$ALT their pivot to bamboo panty liners could save them!
0 · Reply
MySfinktrReeks
MySfinktrReeks Aug. 5 at 9:10 PM
$ALT LOL everyone. We're pinned. Market manipulation. Shorts are scared. We are just plain
0 · Reply
Turribull
Turribull Aug. 5 at 9:06 PM
$ALT Commandments this week: Monday: Thou shalt not breach 3. Tuesday: Thou shalt not fall below 3. Wednesday: Thou shalt be 3. Thursday-Friday rinse and repeat?
4 · Reply
GreenEnergy7B
GreenEnergy7B Aug. 5 at 9:00 PM
0 · Reply
Beebop425
Beebop425 Aug. 5 at 8:52 PM
$ALT https://x.com/KatrinaHelle/status/2085106045614014472?s=20
1 · Reply
Hatrak1
Hatrak1 Aug. 5 at 8:43 PM
$ALT Them SOB's are gonna cheat ! 😆
0 · Reply
MRD85
MRD85 Aug. 5 at 8:34 PM
1 · Reply
Chucho64
Chucho64 Aug. 5 at 8:32 PM
$ALT The volume for the last hour is equal to the volume for the entire morning.🤔🧐🤔🧐
1 · Reply
BuddyBoy6975
BuddyBoy6975 Aug. 5 at 8:29 PM
$ALT Something could happen for us really fast here, .wouldn’t be surprised. And Novo’s not dealing from a position of strength. Far from it
0 · Reply
BuddyBoy6975
BuddyBoy6975 Aug. 5 at 8:17 PM
$ALT I’m sure this is redundant so…
0 · Reply
Chucho64
Chucho64 Aug. 5 at 8:07 PM
$ALT Market open 9:30 = 111k 3:00pm = 1.755 millon 4:00pm = 3.033 millon Only they are operating.🤔🤔
0 · Reply
Hatrak1
Hatrak1 Aug. 5 at 8:00 PM
2 · Reply
blankstocker
blankstocker Aug. 5 at 7:57 PM
$ALT Waiting for the end of day surge like….
0 · Reply
Hatrak1
Hatrak1 Aug. 5 at 7:50 PM
$ALT 😆
0 · Reply
LeaperM75
LeaperM75 Aug. 5 at 7:46 PM
$ALT Perspective. We're in range of previous price points and now we're pinned. Until...
0 · Reply
GreenEnergy7B
GreenEnergy7B Aug. 5 at 7:41 PM
$ALT Definitely feels like Novo and Pfizer will be active on the deal front. That is my takeaway from recent earnings reports
0 · Reply
boyk1ns
boyk1ns Aug. 5 at 7:40 PM
$ALT volume spiking
0 · Reply